Clinical Trials Logo

Clinical Trial Summary

This study investigates the beneficial effects of prefrontal brain stimulation (with a facilitating TMS protocol) before exposure therapy in acrophobic patients. The two exposure sessions were realized in virtual reality. Before and after therapy, the phobic symptoms were measured on a subjective, behavioral and physiological level. The placebo-controlled single blinded study includes 50 phobic patients, which were randomized into verum or sham TMS.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02223767
Study type Interventional
Source Wuerzburg University Hospital
Contact
Status Completed
Phase N/A
Start date August 2014
Completion date October 2015

See also
  Status Clinical Trial Phase
Recruiting NCT04977544 - Virtual Reality Exposure Therapy in the Intensive Treatment of Social Anxiety Disorder N/A
Completed NCT03658252 - Efficacy of Targeted Intervention for Topical Steroid Phobia. N/A
Completed NCT03655262 - Treating Phobia With Multivoxel Neuro-reinforcement N/A
Completed NCT00451750 - Cortisol in the Treatment of Phobias N/A
Completed NCT04782570 - Psychotherapy of Anxiety Disorders With Noninvasive Brain Stimulation - Using Virtual Reality N/A
Recruiting NCT03528109 - Improving Access to Child Anxiety Treatment N/A
Not yet recruiting NCT03813823 - Biobehavioral Correlates of Acute Phobic Fear
Completed NCT02810171 - Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety N/A
Terminated NCT04019054 - TMS and Exposure Therapy N/A
Recruiting NCT03498599 - Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety N/A